Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Systematic analysis of gut microbiome reveals the role of bacterial folate and homocysteine metabolism in Parkinson’s disease
Dorinês Rosário, Gholamreza Bidkhori, Sunjae Lee, et al.
Cell Reports (2021) Vol. 34, Iss. 9, pp. 108807-108807
Open Access | Times Cited: 120

Showing 1-25 of 120 citing articles:

The microbiome–gut–brain axis in Parkinson disease — from basic research to the clinic
Ai Huey Tan, Shen‐Yang Lim, Anthony E. Lang
Nature Reviews Neurology (2022) Vol. 18, Iss. 8, pp. 476-495
Closed Access | Times Cited: 209
Mechanistic Insights into the Link between Gut Dysbiosis and Major Depression: An Extensive Review
Sharma Sonali, Bipul Ray, Hediyal Ahmed Tousif, et al.
Cells (2022) Vol. 11, Iss. 8, pp. 1362-1362
Open Access | Times Cited: 106
The double-edged sword of probiotic supplementation on gut microbiota structure in Helicobacter pylori management
Ali Nabavi-Rad, Amir Sadeghi, Hamid Asadzadeh Aghdaei, et al.
Gut Microbes (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 75
The gut microbiome modulates the transformation of microglial subtypes
Yu Huang, Jing Wu, Hanping Zhang, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 4, pp. 1611-1621
Open Access | Times Cited: 52
Parkinson’s disease and gut microbiota: from clinical to mechanistic and therapeutic studies
Xuxiang Zhang, Beisha Tang, Jifeng Guo
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 48
Gut dysbiosis induces the development of depression-like behavior through abnormal synapse pruning in microglia-mediated by complement C3
Wenzhi Hao, Qingyu Ma, Lu Wang, et al.
Microbiome (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 28
Role of the Gut Bacteria-Derived Metabolite Phenylacetylglutamine in Health and Diseases
Naveen Krishnamoorthy, Manjunath Kalyan, Tousif Ahmed Hediyal, et al.
ACS Omega (2024)
Open Access | Times Cited: 20
Gut microenvironmental changes as a potential trigger in Parkinson’s disease through the gut–brain axis
Szu‐Ju Chen, Chin‐Hsien Lin
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 50
The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment
Angelica Varesi, Lucrezia Irene Maria Campagnoli, Foroogh Fahmideh, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12289-12289
Open Access | Times Cited: 46
Local and systemic effects of microbiome‐derived metabolites
Igor Spivak, Leviel Fluhr, Eran Elinav
EMBO Reports (2022) Vol. 23, Iss. 10
Open Access | Times Cited: 42
Metformin role in Parkinson’s disease: a double-sword effect
Mohammed Alrouji, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 4, pp. 975-991
Closed Access | Times Cited: 40
Integrated Multi‐Cohort Analysis of the Parkinson's Disease Gut Metagenome
Joseph C. Boktor, Gil Sharon, Leo Verhagen Metman, et al.
Movement Disorders (2023) Vol. 38, Iss. 3, pp. 399-409
Open Access | Times Cited: 33
Correlation between the gut microbiome and neurodegenerative diseases: a review of metagenomics evidence
Xiaoyan Liu, Yi Liu, Junlin Liu, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 4, pp. 833-845
Open Access | Times Cited: 29
Effects of microbial-derived biotics (meta/pharma/post-biotics) on the modulation of gut microbiome and metabolome; general aspects and emerging trends
Alireza Sadeghi, Maryam Ebrahimi, Mohammad Saeed Kharazmi, et al.
Food Chemistry (2023) Vol. 411, pp. 135478-135478
Closed Access | Times Cited: 26
Metabolic modelling of the human gut microbiome in type 2 diabetes patients in response to metformin treatment
Bouchra Ezzamouri, Dorinês Rosário, Gholamreza Bidkhori, et al.
npj Systems Biology and Applications (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 26
Mechanistic Insights Into Gut Microbiome Dysbiosis-Mediated Neuroimmune Dysregulation and Protein Misfolding and Clearance in the Pathogenesis of Chronic Neurodegenerative Disorders
Piyush Padhi, Carter Worth, Gary Zenitsky, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 35
Shouhui Tongbian Capsule ameliorates constipation via gut microbiota-5-HT-intestinal motility axis
Jinzhao Bai, Yajie Cai, Zhiyan Huang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113627-113627
Closed Access | Times Cited: 29
Gut microbiota and atopic dermatitis: a two-sample Mendelian randomization study
Yan Xue, Linzhu Zhang, Yajun Chen, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 22
Oral and intestinal dysbiosis in Parkinson's disease
E. Berthouzoz, Vladimir Lazarević, Alkisti Zekeridou, et al.
Revue Neurologique (2023) Vol. 179, Iss. 9, pp. 937-946
Open Access | Times Cited: 20
Chemoselective bicyclobutane-based mass spectrometric detection of biological thiols uncovers human and bacterial metabolites
Amanpreet Kaur, Weifeng Lin, Vladyslav Dovhalyuk, et al.
Chemical Science (2023) Vol. 14, Iss. 20, pp. 5291-5301
Open Access | Times Cited: 19
MIGRENE: The Toolbox for Microbial and Individualized GEMs, Reactobiome and Community Network Modelling
Gholamreza Bidkhori, Saeed Shoaie
Metabolites (2024) Vol. 14, Iss. 3, pp. 132-132
Open Access | Times Cited: 6
Transient colonizing microbes promote gut dysbiosis and functional impairment
Sunjae Lee, Victoria Meslier, Gholamreza Bidkhori, et al.
npj Biofilms and Microbiomes (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 6
Bioactive anti-aging agents and the identification of new anti-oxidant soybean peptides
William Kwame Amakye, Chuanli Hou, Liping Xie, et al.
Food Bioscience (2021) Vol. 42, pp. 101194-101194
Closed Access | Times Cited: 40
Alteration of Gut Microbial Metabolites in the Systemic Circulation of Patients with Parkinson’s Disease
Szu‐Ju Chen, Chieh‐Chang Chen, Hsin-Yu Liao, et al.
Journal of Parkinson s Disease (2022) Vol. 12, Iss. 4, pp. 1219-1230
Closed Access | Times Cited: 27
Host-mycobiome metabolic interactions in health and disease
Neelu Begum, Azadeh Harzandi, Sunjae Lee, et al.
Gut Microbes (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top